A team of researchers at the University of Bern is hoping to be the first to produce a vaccine against Covid-19 and inoculate the entire Swiss population in October. Bachmann, who is also professor of vaccinology at the Jenner Institute at the University of Oxford, said his accelerated timing could be partially explained by potential ease of production, where the equivalent of 200 litres of bacterial bio ferment, which is needed for the jabs, could produce 10-20 million doses. The vaccine under development by the Swiss team takes a different approach than other labs by using so-called virus-like particles, which are not infectious - unlike when using the virus itself - and which provide good immunity response. A prototype was developed in February, just weeks after the new coronavirus was identified in China, and proved successful in tests on laboratory mice, when the serum neutralised the virus. Gary Jennings, CEO of Saiba Biotechexternal link which is working with the University of Bern, said the Swiss authorities are aware of the importance of approving the vaccine's development. �We can do this if the Swiss government and the regulators want to do it. If they want to see this vaccine made available to the public in this timeframe, then it will be done.�